TWAPF (TOWA Pharmaceutical Co) Institutional Ownership: 17.42% (As of Jul. 15, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TWAPF TOWA Pharmaceutical Co Ltd TWAPF
79 GF Score
Price $26.00
GF Value $14.13
Valuation Significantly Overvalued
! 9 Warning Signs
View Full Analysis

What is TOWA Pharmaceutical Co Institutional Ownership?

TOWA Pharmaceutical Co TWAPF 79 Institutional Ownership is 17.42% as of Jul. 15, 2026. GuruFocus rates TWAPF with a GF Score™ of 79/100 and a GF Value™ of $14.13 (Significantly Overvalued). The stock has 9 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, TOWA Pharmaceutical Co's institutional ownership is 17.42%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, TOWA Pharmaceutical Co's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, TOWA Pharmaceutical Co's Float Percentage Of Total Shares Outstanding is 0.00%.

TOWA Pharmaceutical Co Institutional Ownership Historical Data

* Premium members only.

The historical data trend for TOWA Pharmaceutical Co's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

TOWA Pharmaceutical Co Institutional Ownership Chart

TOWA Pharmaceutical Co Historical Data

The historical data trend for TOWA Pharmaceutical Co can be seen below:

2025-09-30 2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30
Institutional Ownership 18.51 18.75 19.12 18.78 18.82 19.26 18.10 18.21 17.90 17.68
TWAPF
79GF Score
TOWA Pharmaceutical Co Ltd TWAPF
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

TOWA Pharmaceutical Co Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 17.42% mean?
TOWA Pharmaceutical Co (TWAPF) has a Institutional Ownership of 17.42% as of Jul. 15, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on TOWA Pharmaceutical Co and its competitors.
Is TOWA Pharmaceutical Co's Institutional Ownership too high?
TOWA Pharmaceutical Co's current Institutional Ownership is 17.42%. Overall, TOWA Pharmaceutical Co has a GF Score™ of 79/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does TOWA Pharmaceutical Co's Institutional Ownership compare to ZTS and UTHR?
TOWA Pharmaceutical Co's Institutional Ownership of 17.42% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Drug Manufacturers company?
A good Institutional Ownership depends on the Drug Manufacturers industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on TOWA Pharmaceutical Co and its competitors. TOWA Pharmaceutical Co's current Institutional Ownership is 17.42%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TOWA Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, TOWA Pharmaceutical Co (TWAPF) is currently considered Significantly Overvalued. The stock's GF Value™ is $14.13, compared to a current price of $26.00 — trading 84% above its estimated fair value. The current Institutional Ownership is 17.42%. TOWA Pharmaceutical Co's overall GF Score™ is 79/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For TOWA Pharmaceutical Co (TWAPF), the current Institutional Ownership is 17.42% as of Jul. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is TOWA Pharmaceutical Co (TWAPF) Overvalued in 2026?

Based on GuruFocus' analysis, TOWA Pharmaceutical Co stock appears to be overvalued. The current stock price of $26.00 is trading 84% above its estimated GF Value™ of $14.13. GuruFocus considers TOWA Pharmaceutical Co to be Significantly Overvalued.

Key valuation signals for TWAPF:

  • Institutional Ownership: 17.42%
  • GF Value™: $14.13 vs. price of $26.00 (84% above fair value)
  • GF Score™: 79/100 with 9 warning signs

No single metric tells the full story. See the TWAPF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

TOWA Pharmaceutical Co Business Description

Other Exchanges 4553:Japan6QC:Germany
Address 2-11, Shinbashi-cho, Kadoma, Osaka, JPN, 571-8580
TOWA Pharmaceutical Co Ltd is a Japan based pharmaceutical company engaged in research and development, production, and marketing of generic drugs. It also provides drug consulting services for patients and their families and relatives. It organizes academic seminars for medical professionals and posts articles in journals. It participates in training for pharmacists. The company has three main plants in operation namely Osaka plant, Okayama plant, and Yamagata plant. Towa has offers more than 500 drugs to meet the diverse therapeutic requirements including lifestyle related diseases such as hypertension and diabetes, digestive system diseases, nervous system diseases and allergic diseases, vitamins and antibiotics.
79GF Score

Get the complete analysis for TWAPF

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$26.00
Price
$14.13
GF Value